EUVIMEDEUVIMED entdecken
Crossref

Phase II Study of Stereotactic Body Radiation Therapy with Simultaneous Integrated Boost (SBRT-SIB) Delivered on an MR-LINAC for Intermediate and High Risk Prostate Cancer: 2 Year Outcomes

E.S. Weg, F. Gregucci, X.K. Zhou, S.T. Tagawa, H. Nagar, A.E. Marciscano, S.C. Formenti

International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S202-S203

DOI: 10.1016/j.ijrobp.2026.06.430 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von E.S. Weg und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Weg, E., Gregucci, F., Zhou, X., Tagawa, S., Nagar, H., Marciscano, A., & Formenti, S. (2026). Phase II Study of Stereotactic Body Radiation Therapy with Simultaneous Integrated Boost (SBRT-SIB) Delivered on an MR-LINAC for Intermediate and High Risk Prostate Cancer: 2 Year Outcomes. International Journal of Radiation Oncology*Biology*Physics, 126(1), S202-S203. https://doi.org/10.1016/j.ijrobp.2026.06.430

Vancouver

Weg E, Gregucci F, Zhou X, Tagawa S, Nagar H, Marciscano A, et al. Phase II Study of Stereotactic Body Radiation Therapy with Simultaneous Integrated Boost (SBRT-SIB) Delivered on an MR-LINAC for Intermediate and High Risk Prostate Cancer: 2 Year Outcomes. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S202-S203. doi:10.1016/j.ijrobp.2026.06.430

BibTeX
@article{Weg2026,
  author = {Weg, E.S. and Gregucci, F. and Zhou, X.K. and Tagawa, S.T. and Nagar, H. and Marciscano, A.E. and Formenti, S.C.},
  title = {Phase II Study of Stereotactic Body Radiation Therapy with Simultaneous Integrated Boost (SBRT-SIB) Delivered on an MR-LINAC for Intermediate and High Risk Prostate Cancer: 2 Year Outcomes},
  journal = {International Journal of Radiation Oncology*Biology*Physics},
  year = {2026},
  volume = {126},
  number = {1},
  pages = {S202--S203},
  doi = {10.1016/j.ijrobp.2026.06.430}
}
Kostenlos starten →